Wednesday May 14, 2025
NEWSLETTER
www.israelhayom.com
  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home Special Coverage Coronavirus Outbreak

Israeli scientists develop 'series of coronavirus antibodies'

The announcement marks the second significant breakthrough in less than a week by scientists at the Israel Institute for Biological Research in central Israel.

by  Yori Yalon
Published on  05-08-2020 13:54
Last modified: 05-08-2020 13:54
Israeli scientists develop 'series of coronavirus antibodies'Getty Images

Some 2,990 Israelis have died from COVID-19 since the outbreak of the pandemic in mid-March | Illustration: Getty Images

Share on FacebookShare on Twitter

President Reuven Rivlin together with Defense Minister Naftali Bennett on Thursday visited the Israel Institute for Biological Research in Nes Ziona, where researchers revealed that they had successfully developed a series of antibodies to combat the coronavirus. 

It was the second such breakthrough this week by IIBR scientists, who earlier this week said they had successfully isolated a key coronavirus antibody.

Follow Israel Hayom on Facebook and Twitter 

Bennet, on Monday, called the step a "significant breakthrough" toward a possible treatment for SARS-CoV-2, the coronavirus that is the source of the COVID-19 pandemic. 

Rivlin met with the scientists spearheading the development of a series of antibodies that effectively neutralize the violent virus through various mechanisms originating in infected people.

The president also discussed the possibility of building a vaccine production plant in Yeroham in southern Israel and urged Bennett to expedite its construction.

IIBR scientists believe the technological breakthrough could shorten the process of finding a cure, which will span several months, and should provide protection even if the virus mutates. 

In the coming days, the IIBR will file a patent for the antibodies it developed and later publish their work in a scientific journal for peer-based review. 

"Last week we celebrated 72 years of independence, and biological independence is critical for the State of Israel," Rivlin said during his visit. "The entire world is hoping for the day an antibody is found, a vaccine, a cure or treatment that will allow us to save lives. From my conversations with world leaders, it's apparent that when it comes to breakthroughs and innovation, their eyes are on us. 

"The process is complex and lengthy, but any breakthrough you achieve is a significant step toward victory. I'm hopeful that the 'deliverer will come out of Zion' – a delivery that will help us guarantee the health of anyone whose life is in danger, allow us to free grandma and grandpa and the entire at-risk population from this difficult quarantine, and to liberate the entire economy," the president said. 

"This institution is our pride," he told the researchers. "Thank you, you are the glory of the State of Israel."

Bennett said: "This is a great day for Israel. This is another tremendous Israeli breakthrough in less than a week, which will help us cope not only with the current strain of the coronavirus but with possible mutations. I instructed the defense establishment and the IIBR to move ahead at the highest speed to develop a mass cure. We will not spare money or resources and do everything in our power to shorten the time it takes to have a commercial medicine."

Tags: bennettCOVID-19Israel Institute for Biological ResearchRivlintreatmentvaccine

Related Posts

A bat from the past? Scientists identify new Covid-like virusThomas Peter/Reuters

A bat from the past? Scientists identify new Covid-like virus

by Adi Nirman

Discovery at Wuhan facility shows virus uses similar cell entry mechanism as COVID-19.

Israel reinstates PCR tests at Ben-Gurion AirportYossi Zeliger

Israel reinstates PCR tests at Ben-Gurion Airport

by Shimon Yaish

Travelers returning from abroad can be tested for COVID at the government's expense. Testing is voluntary, for now.

Israel launches COVID vaccination campaign for children 5 and youngerGetty Images

Israel launches COVID vaccination campaign for children 5 and younger

by Maytal Yasur Beit-Or

Parents inoculating young children will be able to choose between Moderna and Pfizer shots. Healthcare providers stress the importance of...

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il